You will guide a team focused on oral solid dosage forms for Phase I and II, including enabling formulations for poorly soluble compounds—work that directly influences how quickly patients see the benefit of breakthrough therapies
Job Summary
You will guide a team focused on oral solid dosage forms for Phase I and II, including enabling formulations for poorly soluble compounds—work that directly influences how quickly patients see the benefit of breakthrough therapies.
We combine deep disease understanding with digital, data science and AI to better predict clinical success and shorten the path to patients.
We value kindness alongside ambition, and we expect thoughtful challenge as we aim for the greatest and swiftest impact on disease.
Matching Summary
You will guide a team focused on oral solid dosage forms for Phase I and II, including enabling formulations for poorly soluble compounds—work that directly influences how quickly patients see the benefit of breakthrough therapies.
Skills & Requirements
Must-have
Developing oral solid dosage forms
Leading high-performing scientific teams
Formulation for poorly soluble compounds
Cross-functional global collaboration
Quality, SHE and regulatory compliance
Digital, predictive science and automation
Nice-to-have
Experience with GMP clinical supplies
Expertise in enabling formulation technologies
Design of experiments and process modeling
Automation platforms and data analytics
Partnering with CDMOs/CROs
Building inclusive teams across sites
Key Requirements
At least 10 years industry experience
BSc, MSc, PhD or equivalent in pharmaceutical science or related fields
Proven leadership of scientific teams
Experience in early clinical phase pharmaceutical development
Knowledge of quality, SHE and regulatory requirements